Biden to dump another $5BILLION of taxpayer cash into developing NEW COVID vaccines

Share This Post


The White House plans to devote $5billion to develop treatments and vaccines effective against the entire family of coronaviruses, not just Covid.

‘Project Next Gen’ is expected to be launched in the near future as a sequel to the Trump Administration’s ‘Operation Warp Speed’. The funding will be taken from money put aside by the Department of Health and Human Services for Covid tests and PPE.

Similar to the landmark project that lead to the quick development of the Moderna Covid vaccines, the government will work with private companies to fund and assist with research and development of the shots.

The goal is to develop a ‘Pan-Coronavirus’ vaccine, and treatments that will be able to withstand future threats from the family of viruses that includes Covid, SARS and MERS.

But, interest in the pandemic and the vaccines has greatly diminished, with some questioning why the funds would be spent this way. 

President Biden (pictured) is set to launch a $5billion initiative to develop vaccines and therapeutics effective against Covid and other strains of coronavirus

President Biden (pictured) is set to launch a $5billion initiative to develop vaccines and therapeutics effective against Covid and other strains of coronavirus

‘It’s been very clear to us that the market on this is moving very slowly,’ Dr Ashish Jhan, the White House’s Covid response coordinator told the Washington Post. 

‘There’s a lot that government can do, the administration can do, to speed up those tools … for the American people.’ 

The initiative will have three major goals. First, to create a mucosal vaccine against Covid that is effective at preventing infection from the virus.

This means that instead of through a jab, the vaccine will be administered either through the nose or orally. 

This was the goal of the initial Covid vaccines, launched in late 2020 partly assisted by Operation Warp Speed.

At first, the shots could drop the risk of Covid infection by around 90 percent. But, this greatly fell after the eruption of the Omicron variant in late 2021.

The current set of bivalent Covid vaccines are tailored to Omicron, but still are not particularly effective at preventing infection or transmission.

Biden officials are also hoping their injection of case could fuel the development of monoclonal antibodies that remain effective against all strains of the virus.

Many drugs of this class received early emergency authorization from the Food and Drug Administration (FDA) to fight the virus. It was the main tool used in many American hospitals.

But like the vaccines, these drugs’ effectiveness significantly fell once Omicron emerged. They have now been removed as treatments for the virus.

The most-lofty of the trio of goals is to develop a vaccine effective against all types of coronaviruses.

This would not just include Covid, but both previous and future versions of it that may erupt.

Over the past three decades, three major coronavirus outbreaks have emerged across the world.

WaPo reports that Biden had wanted to get this initiative underway for around a year but struggled to convince Congress to fund it. Now using HHS funds, it will finally get underway.

Dr Jha did not share a timetable as to when the mentioned drugs and vaccines could become available.

He says that once they are developed, the scientific findings could also spur innovation for vaccines and treatments for other conditions too.

When the initiative is officially launched the first task for health officials is identifying which projects underway in the private sector are worth funding.

Among these potential candidates is a class of nasal vaccines that have shown promise in early clinical trials. 

Georgia-based startup Blue Lake Biotechnology Inc are the manufacturers of one of the mucosal vaccine candidates.

Their vaccine, which is sprayed up a person’s nose, could reduce the likelihood of catching the virus by 86 percent when used as a booster dose in early trials.

These first trials only included 72 participants and the firm is looking towards bigger studies to prove the shot’s effectiveness.

Nasal vaccines have been seen by many as a critical piece of the future Covid response.

Some hope the sprays will be more palatable for parents to give their young children and help get the inoculation to some who are vaccine-hesitant.

It can also be simply administered by a person at home in some cases. 

This story is still developing 



Source link

Related Posts

A Journey of Thousand Years – Organza fabric

With its delicate sheerness and unreal texture, Organza fabric...

Wedding Photography in Bristol, UK Capturing Moments That Last Forever

The wedding day is the beginning of a beautiful...

Plan the Perfect Group Trip with Tour Bus From Cincinnati

Getting on the road and driving through deserts, beaches,...

10 Yoga for PCOS: Steps to Follow and Yoga Tips for PCOD

Introduction to PCOS and its Impact on Fertility Polycystic Ovary...

All you Need to Know – Probiotic Food Supplement

Health and medicine are two of the few sectors...

Seeking Justice: How a Jeep Lemon Lawyer Can Fight for You

Owning a Jeep is supposed to be an adventure,...
- Advertisement -spot_img